(Press Release | 2023-06-05 18:44:19) WALTHAM, Mass. and GELEEN, Netherlands – June 5, 2023 – Temple Therapeutics, a biotechnology company pioneering a female-focused precision medicine approach, released the publication of its Phase [ Read More ]

(Press Release | 2023-05-19 23:54:14) Home care by family members is the most common form of care. In Austria alone, 70% of all people in need of care are cared for by family members or informal networks. It is widely known that the care [ Read More ]

(Press Release | 2023-04-19 23:46:24) Surprise! One natural remedy that's been proven in a research study to relieve hot flashes may be unexpected to some. It's such a well-known, widely used vitamin with many benefits. It’s the [ Read More ]

(Press Release | 2023-03-02 13:03:04) Krems (Austria), 02. March, 2023: For those affected by B-cell cancer, a third SARS-CoV-2 vaccination is of particular importance. The 3rd vaccination often results in detectable antibody production [ Read More ]

(Press Release | 2023-01-18 13:03:31) Krems (Austria), 18. January, 2023 – The distinction between primary tumors and metastases can be made quickly and accurately in brain tumors using radiomics and deep learning algorithms. This is [ Read More ]

(Press Release | 2022-12-15 16:48:24) - High reliability of AI based radiological image analysis of hip joints - Up to 90% time saving with AI-based measures compared to human assessment - More than 80 % savings on labor [ Read More ]

(Press Release | 2022-11-22 13:57:56) Krems, Austria, 22. November 2022: Immune responses against Factor VIII, which is used to treat hemophilia A (bleeding disorder), are influenced by the microenvironment of antigen presenting cells. [ Read More ]

(Press Release | 2022-10-19 14:56:22) Vienna, Austria, 19. October, 2022 – One of the most advanced AI-based image analysis platforms for bone disease diagnostics will get rolled out at the radiology and orthopedic departments of the [ Read More ]

(Press Release | 2022-09-22 13:08:49) Krems (Austria), 22. September 2022 – Nearly half of all patients who are admitted alive to hospital after traumatic brain injury involving objects penetrating the brain are able to survive. That's [ Read More ]

(Press Release | 2022-09-13 16:40:17) Krems (Austria), 13. September 2022 – An Austrian study demonstrates an anti-tumor effect of certain nature-derived cyclic peptides. The study, which has now been published internationally, not [ Read More ]

(Press Release | 2022-09-07 14:05:03) St. Pölten/Krems, Austria, 7. September 2022: When the anti-epileptic drug levetiracetam (LEV) is administered in the course of tumor removal surgery, cognitive abilities are preserved before and [ Read More ]

(Press Release | 2022-08-17 21:27:06) Krems (Austria), 17. August 2022 - Nursing care is being digitized at a rapid pace, but many ethical questions about it remain unanswered. Initial answers were provided by an international symposium [ Read More ]

(Press Release | 2022-06-21 23:57:39) Krems (Austria), 21. June 2022: The classification of brain tumors – and thus the choice of optimal treatment options – can become more accurate and precise through the use of artificial [ Read More ]

(Press Release | 2022-05-25 14:29:22) Krems (Austria), May 24th, 2022: Inflammation of the skin and the esophagus, food allergy and asthma are just some of the symptoms of a now 12-year-old boy who was the first to have a mutation on the [ Read More ]

(Press Release | 2022-04-30 19:48:28) Krems (Austria), April 27th, 2022 – The growing use of smart control and monitoring tools in nursing increasingly decouples it from ethical and moral considerations - this is the core thesis of a [ Read More ]

(Press Release | 2022-04-19 15:26:35) Temos International and the General Authority for Healthcare Accreditation and Regulation of Egypt (GAHAR) have signed an agreement to jointly cooperate in healthcare facilities' accreditation. As [ Read More ]

(Press Release | 2022-03-30 13:10:45) Krems, Austria, March 30th, 2022 –Factors such as anemia and anticoagulants have more impact on hospitalization time after breast reconstruction than "common" risk factors. That is the outcome of a [ Read More ]

(Press Release | 2022-03-28 11:35:58) Heidelberg, March 28, 2022 – TolerogenixX GmbH, a biopharmaceutical company developing personalized cellular therapies aimed at achieving sustained immune tolerance to combat organ rejection and [ Read More ]

(Press Release | 2022-03-16 11:10:47) JERUSALEM, Israel, March 16, 2022 -- Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, today announced it [ Read More ]

(Press Release | 2022-03-05 23:23:56) Krems, 04. March 2022 - For the first time, the high safety and low mortality of a still novel, simpler procedure for lung biopsies has also been shown in a European context. The so-called [ Read More ]